We and others have reported the increased adipose tissue IL-6 expression in obesity/T2D which could have consequences either as a circulating pleiotropic adipocytokine or as a local regulator of adipose inflammation and insulin action [15,16,17]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.